Rick Leveridge has been practicing law for over 40 years. His affiliation with Gilbert started in 1997 when he and the founders of Gilbert LLP were partners at the national law firm of Dickstein Shapiro LLP. Rick rejoined Gilbert as a partner in 2018. Since that time, he has led a number of litigation teams, including those representing the States of Delaware and Ohio and a number of Indian Tribes against certain manufacturers, distributors and dispensers of opioids. He is also representing the governmental opioids claimants as co-plaintiffs with the Debtors and the Official Committee of Unsecured Creditors in the Purdue Pharma Bankruptcy Adversary Proceeding involving coverage for opioids claims under the Debtors’ insurance policies.
In addition, Rick leads Gilbert’s antitrust litigation practice and is actively involved as co-lead counsel for the class of plaintiffs in In re Credit Default Swaps Auctions Litigation (D.N.M.).
Over the years, Rick’s litigation practice has encompassed cases involving a wide range of subject matters, including cases related to the aviation, agribusiness, corrugated paper, chemical, computer, credit card, banking, energy, and construction industries. He has represented clients in federal and state courts throughout the country. Rick and his litigation teams have recovered more than $3.5 billion for clients.
Rick focuses his practice on serving corporate clients who suffered business injuries as a result of illegal price-fixing cartels in the United States and abroad. Notable cases where Rick took a lead position on behalf of his corporate clients include: In re Vitamins; In re Linerboard; In re Urethanes Antitrust Litigation; Federal Home Loan Mortgage v. Bank of America, et al. (LIBOR); and In re Citric Acid. Rick’s antitrust experience also includes a defense-side practice.
Past representative matters include:
NEWS & PUBLICATIONS